These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Axenic growth and drug sensitivity studies of Balamuthia mandrillaris, an agent of amebic meningoencephalitis in humans and other animals. Schuster FL, Visvesvara GS. J Clin Microbiol; 1996 Feb; 34(2):385-8. PubMed ID: 8789020 [Abstract] [Full Text] [Related]
8. Free-living amebas: infection of the central nervous system. Martinez AJ. Mt Sinai J Med; 1993 Sep; 60(4):271-8. PubMed ID: 8232369 [Abstract] [Full Text] [Related]
9. Opportunistic amoebae: challenges in prophylaxis and treatment. Schuster FL, Visvesvara GS. Drug Resist Updat; 2004 Feb; 7(1):41-51. PubMed ID: 15072770 [Abstract] [Full Text] [Related]
13. Identification of plicamycin, TG02, panobinostat, lestaurtinib, and GDC-0084 as promising compounds for the treatment of central nervous system infections caused by the free-living amebae Naegleria, Acanthamoeba and Balamuthia. Kangussu-Marcolino MM, Ehrenkaufer GM, Chen E, Debnath A, Singh U. Int J Parasitol Drugs Drug Resist; 2019 Dec; 11():80-94. PubMed ID: 31707263 [Abstract] [Full Text] [Related]
14. In-vitro activity of miltefosine and voriconazole on clinical isolates of free-living amebas: Balamuthia mandrillaris, Acanthamoeba spp., and Naegleria fowleri. Schuster FL, Guglielmo BJ, Visvesvara GS. J Eukaryot Microbiol; 2006 Dec; 53(2):121-6. PubMed ID: 16579814 [Abstract] [Full Text] [Related]
17. Culture isolation of Acanthamoeba species and leptomyxid amebas from patients with amebic meningoencephalitis, including two patients with AIDS. Gordon SM, Steinberg JP, DuPuis MH, Kozarsky PE, Nickerson JF, Visvesvara GS. Clin Infect Dis; 1992 Dec; 15(6):1024-30. PubMed ID: 1457633 [Abstract] [Full Text] [Related]